- People have the right to know.
- Ivermectin is safer than commonly used medicines like Ibuprofen, paracetamol, penicillin and aspirin.
- By August 2020, Ivermectin was being used in Bangladesh, Mexico, South Africa, Israel, Spain, Italy, Slovakia and Japan, besides in the US, UK and many countries in Europe.
- Ivermectin is Now a Therapeutic Option for Doctors & Prescribers! | Jan 14, 2021.
- Powerful New Evidence for Reducing COVID-19 Deaths Using Ivermectin |
June 20, 2021.
How to prevent a third wave of Covid-19
Drug control authorities around the world chose to dismiss or stay indifferent to the sustained efficacy of Ivermectin despite studies showing its effectiveness.
(Express Illustration: Amit Bandre)
Published: 30th June 2021
By Dr Kavery Nambisan & Dr Darrell Demello
This is the first time in the history of a disease that its course is so anxiously charted and its possible surge predicted months in advance. Medical experts in India have forewarned of a third wave in the near future. Our government is pushing hard with vaccinations. But we have to ask the question: Even if vaccination is the best Covid terminator, is it the only one?
All estimates confirm that it will take eight to ten months to vaccinate an adequate number of people in our country. During that time, those who are unprotected while waiting for the vaccine will be vulnerable to infection. As lockdowns are relaxed, the virus will spread. Given the likelihood and the dreaded implications of a third wave, we need to look at other possibilities of halting the virus.
People have the right to know:
In 1979, two scientists Campbell and Omura discovered the drug Ivermectin, which was found to be effective against a number of parasitic infestations.
The drug was produced by the pharmaceutical company Merck and in the last 40 years of its use, 3.7 billion tablets have been consumed worldwide.
It figures in the WHO list of essential drugs. The two scientists were awarded the Nobel Prize in Chemistry for their discovery.
Ivermectin is safer than commonly used medicines like Ibuprofen, paracetamol, penicillin and aspirin.
In India, every medical practitioner is familiar with this drug that is also safe for children. However, parasitic infestations are the bane of economically backward countries in Africa and Asia. For the manufacturer, it is not a profit-making drug, so Merck did not renew its patent after the early years. Ivermectin is now being produced by several companies.
__
https://twitter.com/GraviolaDOTfi/status/1387093034098122758?s=20The 'Era of #Ivermectin #India' began in August 2020. pic.twitter.com/LbOHmEXxyd
— Graviola Finland (@GraviolaDOTfi) April 27, 2021
__
In 2020, during the early months of the pandemic, an Australian scientist experimenting with Ivermectin in vitro found that it killed the Covid-19 virus. He wrote about his findings and it was noted by a doctor working in a large government hospital in Bangladesh. He used Ivermectin on 60 patients and found that it cured most of them. Moreover, none of them developed any serious complications of the disease.
As the news of this drug being effective in treating Covid spread, hundreds and then thousands of doctors began to use it all over the world. The results were extraordinary: When given in the early stage of viral replication (first five days) and along with other supportive vitamins, Ivermectin is far more effective than other more expensive drugs. In later stages of the disease also it works because of its anti-inflammatory properties that help avoid serious complications.
By August 2020, Ivermectin was being used in Bangladesh, Mexico, South Africa, Israel, Spain, Italy, Slovakia and Japan, besides in the US, UK and many countries in Europe.
In India, a doctor in Deoria district of Uttar Pradesh has treated over 4,000 patients; another in Kandivali, Mumbai, has treated 6,000 (most of them from corporate houses) and a professor of ENT working in Mangaluru has treated over 4,000 patients. There are many others who have treated patients in large numbers. Those of us who work in smaller towns and rural areas have experience with several hundreds.
Ivermectin is also used as a preventive medicine for those who are at high risk of infection, like family members of Covid positive individuals and all frontline workers, which includes healthcare professionals, the police, traffic and railway personnel, bus, auto and taxi drivers, bank employees and more. It is useful in treating post-Covid complications and long Covid, although the most dramatic results are seen when it is used early. We believe that this drug should be quickly cleared for use countrywide and also provided to ASHA workers in their health kits, with clear instructions for use. In fact, Ivermectin should be given to all those who are not vaccinated or are partially vaccinated. After the initial three tablets given on three consecutive days, a once-weekly dose of 12 mg provides enough protection against the virus. When a drug that is safe and cheaply available can work effectively during the waiting period for the vaccine, is there any reason not to use it? Mass prophylaxis is a sure way of stopping transmission. It should be urgently implemented by the Centre, because all mechanisms of mutation and spread are not only of national but also international significance.
In December 2020, a group of medical experts formed the international Front-Line Covid-19 Critical Care Alliance (FLCCC) led by Drs Paul Marik, Umerto Meduri, Jose Inglesias, Peirre Kory and Joe Varon. In the UK, the British Ivermectin Recommendation Development panel (BIRD) was founded by a team led by Dr Lawrie. To date, there have been over 60 clinical trials and 31 randomised clinical trials done on 25,000 patients by 549 scientists on Ivermectin use in Covid-19 infections. They firmly endorse the universal use of the drug.
__
Ivermectin is Now a Therapeutic Option for Doctors & Prescribers! | Jan 14, 2021
— Graviola Finland (@GraviolaDOTfi) January 17, 2021
– after Dr. Paul Marik and Dr. Pierre Kory – founding members of the FLCCC along with Dr. Andrew Hill (WHO), presented their data before the NIH Treatment Guidelines Panel.https://t.co/H9RuWT13DH pic.twitter.com/YyHMIGGA11
https://twitter.com/GraviolaDOTfi/status/1350714845096792064
https://archive.vn/jeQG5
__
However, there is one dilemma:
Major pharmaceutical companies around the world have invested trillions of dollars in the manufacture of vaccines. One can understand their need to recover costs and make profits by selling vaccines to every country.
But it should not mean that we sacrifice millions of lives in order to make it okay for the companies. Sadly, this is happening. Drug control authorities around the world and (ironically) WHO itself chose to dismiss or stay indifferent to the sustained efficacy of Ivermectin. Medical professionals who work in super-speciality hospitals are none too happy about a drug that will drastically reduce hospital dependency.
The saddest part of the story is that the media has apparently chosen to look only at one side of the coin. What other explanation is there for the shrill publicity given to expensive drugs like Remdesivir and several newer drugs while the success, safety and ease of use of Ivermectin is treated with deafening silence? If patients can recover quickly with a tablet that can be taken at home, we can undo lockdowns, open up business and tourism, and run colleges and schools without waiting until the whole world is vaccinated. None of this is to say that vaccinations are not necessary. What we are trying to reinforce is that we should use the simpler, safer, quicker method of mass prophylaxis with Ivermectin as soon as possible. If properly planned, it can be done in a matter of days.
To put it simply, it makes very good sense to Ivermectinise the world while going ahead with vaccinations at the same time. Given the crumbling economy of many poor countries, universal vaccination is a long way off. Every single Covid patient is a risk to herself and the rest of the world.
In conclusion, we quote Michael Capuzzo, a five-time Pulizer shortlisted writer from his article on Ivermectin titled The Drug that Cracked Covid. He writes: “I do not know of a bigger story in the world than this.”
Surgeon and writer, practising in Kodagu district, Karnataka
(kavery.nambisan@gmail.com)
Dr Darrell Demello
Leading telemedicine practitioner from Kandivali, Mumbai
(darrelldemello@gmail.com)
(Dr Demello has treated over 7,000 Covid patients)
ALSO WATCH | How Mumbai, India's most crowded city, beat the odds, and the coronavirus:
___
How to prevent a third wave of Covid-19
"We should use the simpler, safer, quicker method of mass prophylaxis with Ivermectin as soon as possible.
It makes very good sense to Ivermectinise the world while going ahead with vaccinations at the same time." https://t.co/FNQ5uWgdsV pic.twitter.com/z9TkCJcBVN— J Chamie (@jjchamie) July 4, 2021
___
GAME'S OVER *******S: Indictments NOW | 2021-01-15 10:28 by Karl Denninger
— Graviola Finland (@GraviolaDOTfi) January 16, 2021
- NIH has upgraded their recommendation and now considers #Ivermectin an option for use in #COVID-19.
- including Fauci, criminally prosecuted. https://t.co/r7tA74szjp pic.twitter.com/qSonhekMhJ
https://archive.vn/ARf8q
___
___
The Science
June 20, 2021
Powerful New Evidence for Reducing COVID-19 Deaths Using Ivermectin
Just published online by the American Journal of Therapeutics, Ivermectin for Prevention and Treatment of COVID-19 Infection: A Systematic Review, Meta-analysis, and Trial Sequential Analysis to Inform Clinical Guidelines concludes: “Moderate-certainty evidence finds that large reductions in COVID-19 deaths are possible using ivermectin. Using ivermectin early in the clinical course may reduce numbers progressing to severe disease. The apparent safety and low cost suggest that ivermectin is likely to have a significant impact on the SARS-CoV-2 pandemic globally.”
View Abstract | View PDF Paper
https://journals.lww.com/americantherapeutics/Abstract/9000/Ivermectin_for_Prevention_and_Treatment_of.98040.aspx
Releae About New Oxford Study June 23, 2021
From today, ivermectin is being investigated in the UK as part of the Platform Randomised Trial of Treatments in the Community for Epidemic and Pandemic Illnesses (PRINCIPLE), the world’s largest clinical trial of possible COVID-19 treatments for recovery at home and in other non-hospital settings.
Led by the University of Oxford, PRINCIPLE is investigating treatments for people at more risk of serious illness from COVID-19 which can speed up recovery, reduce the severity of symptoms and prevent the need for hospital admission. The study has so far recruited more than 5,000 volunteers from across the UK. Ivermectin is the seventh treatment to be investigated in the PRINCIPLE trial, and is currently being evaluated alongside the influenza antiviral favipiravir. To find out more about the study, visit www.principletrial.org
New Protocol Release June 16, 2021
I-RECOVER Management Protocol For Long Haul COVID-19 Syndrome
The FLCCC Alliance is proud to announce the establishment of a treatment protocol called “I-RECOVER”, intended for patients suffering from Long Haul COVID-19 Syndrome. I-RECOVER is a consensus protocol developed in a collaboration led by Dr. Mobeen Syed (“Dr. Been”), Dr. Ram Yogendra, Dr. Bruce Patterson, Dr. Tina Peers, and the FLCCC Alliance. The protocol is based on the group’s collective experiences using a selection of therapies centered around the drug ivermectin which produced consistent, sustained, and often profound clinical responses. This protocol has also been used to treat post-vaccine inflammatory syndromes with similar success … Learn More
Information June 7, 2021
The Latest Results of Ivermectin’s Success in Treating Outbreaks of COVID-19. Click image to enlarge details.
Review Article April 5, 2021
Global trends in clinical studies of ivermectin in COVID-19
Dr. Satoshi Ōmura, co-author of the newly published paper, “Global trends in clinical studies of ivermectin in COVID-19” was one of the four researchers from Kitasato University in Tokyo, Japan who received the Nobel Prize in Physiology or Medicine in 2015 for their discovery of ivermectin. Read More
I-MASS – Prevention & At Home Treatment Mass Distribution Protocol for COVID-19 (updated June 2, 2021)
The I-MASS Protocol was created for generalized distribution during mass outbreaks and in low-resource countries. To achieve maximal impact as well as ease of deployment with the lowest burden of required elements, the I-MASS treatment approach is centered on the fewest, core, high impact elements such as the drug Ivermectin, an anti-parasitic medicine that is on the WHO’s list of essential medicines, has been given 3.7 billion times around the globe, and has won the Nobel prize in 2015 for its global and historic impacts in eradicating endemic parasitic infections in many parts of the world… Learn More
Public Statement April 29, 2021
Front Line COVID-19 Critical Care Alliance Statement on New Guidance on Ivermectin from the All India Institute of Medical Science
WASHINGTON, D.C. – The Front Line COVID-19 Critical Care Alliance (FLCCC), a group of highly published, world-renowned critical care physicians and scholars, today praised the recent updated guidance from the All India Institute of Medical Science (AIIMS) to include ivermectin in its guidelines for the treatment of COVID-19. Read Full Statement
Only 8 hours after this COVID-19 patient took ivermectin, she snapped back to health (April 21, 2021) Read More
Please regard our Help pages – and also share the 20+ Translations of our COVID-19 protocols with your networks, friends and colleagues around the world!
WEBINAR
Weekly Update · Live · Every Wednesday · 7 pm ET
Dr. Pierre Kory, FLCCC President & Chief Medical Officer, joins host Betsy Ashton, FLCCC Creative Director, every Wednesday to feature the latest information about our MATH+ and I-MASK+ protocols, status updates about the pandemic, emerging COVlD-19 therapeutics—and YOUR questions.
Press Release April 9, 2021
Front Line COVID-19 Critical Care Alliance Statement on Recent Washington Post Story
WASHINGTON, D.C. – We appreciate the interest from the Washington Post in the use of ivermectin as a safe and effective preventative and treatment for COVID-19. However, the article published yesterday left out several key components of the complete story of how ivermectin is saving lives all over the world. These include the overwhelming amount of data on ivermectin… Read full release
___
In-Depth Precautions and Warning
VastaaPoistaDrug Warnings
Do now not take Buy isotroin 20 mg online if you are pregnant or breastfeeding as it may cause unfavorable outcomes within the baby. If you've got despair or any suicidal mind whilst taking Isotroin 20 Capsule 10's or after stopping remedy with Isotroin 20 Capsule 10's, please consult a health practitioner. Avoid solar exposure even as the use of Isotroin 20 Capsule 10's as it can make the pores and skin greater touchy to daylight and cause sunburn. Wear shielding apparel and use a sunscreen even as going out to guard your skin from sunburn. Do no longer go through any beauty techniques even as taking Isotroin 20 Capsule 10's and for minimal 6 months after preventing remedy with Isotroin 20 Capsule 10's as it is able to growth the danger of scarring. Inform your health practitioner when you have asthma, diabetes, hypervitaminosis A (excessive tiers of diet A), liver or coronary heart issues, weak bones, osteoporosis (bone loss), anorexia nervosa (an ingesting disease wherein human beings eat too little), any intellectual issues together with psychosis (lack of contact with fact) or despair before taking Isotroin 20 Capsule 10's.